SEC Form 4 · accession 0000886163-15-000120
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd C Davis
Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 6:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 7, 2015 | G | 50 | — | D | 55,399 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Charitable gift to a third party.